Dr Oludare Odumosu Archives | Cannabiz

News in brief: Shahin becomes Vitura’s largest shareholder; Avecho progresses CBD insomnia trial; Epsilon reports improved cashflow; Zelira locks in R&D loan to advance trial

by Adam Sheldon July 31, 2025July 31, 2025

Prominent businessman and investor Professor Charlie Shahin has become the largest shareholder in Vitura Health after […]

Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix

by Steve Jones and Martin Lane January 31, 2024July 11, 2024

Zelira share price rockets as study shows cannabinoid drug outperforms multibillion dollar Pfizer product

by Steve Jones June 1, 2023April 30, 2024

Zelira

Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma

by Martin Lane and Steve Jones May 23, 2023April 30, 2024

Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics

by Martin Lane March 16, 2023April 30, 2024

Company news: Neurotech; Emyria; Cann Group; Incannex; Creso Pharma; Greenfern; Zelira; Organic Genetics

by Martin Lane November 24, 2022April 29, 2024

Zelira

Company news: Zelira Therapeutics; Hygrovest; Epsilon Healthcare

by Martin Lane September 22, 2022April 29, 2024

Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience

by Steve Jones and Martin Lane September 1, 2022April 29, 2024

Zelira

Zelira’s ‘multiple shots on goal’ will drive profitability, says global CEO

by Steve Jones June 30, 2022April 29, 2024

Zelira’s Health House acquisition called off

by Martin Lane and Steve Jones June 22, 2022April 29, 2024